• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脉冲染料激光治疗显性营养不良型大疱性表皮松解症后红斑改善,水疱减少。

Improved erythema and decreased blister formation in dominant dystrophic epidermolysis bullosa following treatment with pulsed dye laser.

机构信息

Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Department of Pediatrics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

出版信息

Pediatr Dermatol. 2022 Nov;39(6):1005-1006. doi: 10.1111/pde.15126. Epub 2022 Sep 5.

DOI:10.1111/pde.15126
PMID:36063122
Abstract

Dominant dystrophic epidermolysis bullosa (DDEB), an inherited disorder due to type VII collagen mutations, is characterized by blisters and erosions that heal with scarring, atrophy, and milia. There is no established role for laser in the management of patients with DDEB. Pulsed dye laser (PDL) is most often used to target vascular skin lesions. We describe a patient with DDEB with marked improvement in erythema as well as fewer and less symptomatic episodes of blistering following treatment with PDL.

摘要

显性营养不良型大疱性表皮松解症(DDEB)是一种遗传性疾病,由 VII 型胶原基因突变引起,其特征是水疱和糜烂,愈合后会留下瘢痕、萎缩和粟丘疹。激光在 DDEB 患者的治疗中没有明确的作用。脉冲染料激光(PDL)最常用于治疗血管性皮肤病变。我们描述了一例 DDEB 患者,在接受 PDL 治疗后,红斑明显改善,水疱发作次数减少,症状减轻。

相似文献

1
Improved erythema and decreased blister formation in dominant dystrophic epidermolysis bullosa following treatment with pulsed dye laser.脉冲染料激光治疗显性营养不良型大疱性表皮松解症后红斑改善,水疱减少。
Pediatr Dermatol. 2022 Nov;39(6):1005-1006. doi: 10.1111/pde.15126. Epub 2022 Sep 5.
2
Dystrophic Epidermolysis Bullosa营养不良性大疱性表皮松解症
3
Exon 87 skipping of the COL7A1 gene in dominant dystrophic epidermolysis bullosa.COL7A1 基因外显子 87 跳跃导致显性营养不良型大疱性表皮松解症。
J Dermatol. 2011 May;38(5):489-92. doi: 10.1111/j.1346-8138.2010.01008.x. Epub 2010 Sep 20.
4
Esophageal stenosis in childhood: dystrophic epidermolysis bullosa without skin blistering due to collagen VII mutations.儿童期食管狭窄:因VII型胶原突变导致无皮肤水疱的营养不良性大疱性表皮松解症。
Gastroenterology. 2002 Jan;122(1):220-5. doi: 10.1053/gast.2002.30428.
5
Multiple Milia as an Isolated Skin Manifestation of Dominant Dystrophic Epidermolysis Bullosa: Evidence of Phenotypic Variability.多发性粟丘疹作为显性营养不良性大疱性表皮松解症的孤立性皮肤表现:表型变异性的证据
Pediatr Dermatol. 2017 Mar;34(2):e106-e108. doi: 10.1111/pde.13047. Epub 2016 Dec 23.
6
Mouse models for dominant dystrophic epidermolysis bullosa carrying common human point mutations recapitulate the human disease.携带常见人类点突变的显性营养不良性大疱性表皮松解症的小鼠模型重现了人类疾病。
Dis Model Mech. 2021 Jun 1;14(6). doi: 10.1242/dmm.048082. Epub 2021 Jun 4.
7
Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect.显性营养不良型大疱性表皮松解症大鼠模型:甘氨酸取代降低 VII 型胶原稳定性并显示出基因剂量效应。
PLoS One. 2013 May 23;8(5):e64243. doi: 10.1371/journal.pone.0064243. Print 2013.
8
Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa.患者患有营养不良性大疱性表皮松解症的眼基因治疗。
N Engl J Med. 2024 Feb 8;390(6):530-535. doi: 10.1056/NEJMoa2301244.
9
Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.成人获得性大疱性表皮松解症(EB)伴先前未识别的轻度营养不良性 EB 和 COL7A1 双等位基因突变
Acta Derm Venereol. 2018 Apr 16;98(4):411-415. doi: 10.2340/00015555-2851.
10
Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.遗传性营养不良性大疱性表皮松解症与鳞状细胞癌——病例报告
Indian J Pathol Microbiol. 2023 Apr-Jun;66(2):360-362. doi: 10.4103/ijpm.ijpm_249_21.

引用本文的文献

1
Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects.营养不良性大疱性表皮松解症(DEB)治疗的创新:现状与前景
Ther Clin Risk Manag. 2023 Jun 14;19:455-473. doi: 10.2147/TCRM.S386923. eCollection 2023.